•  
  •  
  •  
  •  

2025-10-06 17:09:28

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • HCLTech joins MIT Media Lab in the US to collaborate on next-gen AI research
  • TVS Motor Company launches most advanced TVS Raider variant
  • Zydus receives final approval from USFDA for Deflazacort oral suspension, 22.75 mg/mL
  • Deepak Group Unveils State-of-the-Art Next-Generation R&D Centre to Pioneer Innovations in Chemistry
  • Smt. Bhuvaneswari Nara selected for IOD's Distinguished Fellowship - 2025

Keywords Selected:  Jyoti

Stock Report

  • Jyoti Ltd secures LOI for order worth Rs. 43.07 crores
  • Jyoti Ltd secures order of Rs. 6.45 crores
  • Jyoti Ltd receives LOI for order worth Rs. 6.35 crores
  • Jyoti Ltd to allot 59,63,636 shares to Rare Asset Reconstruction ltd
  • Jyoti Ltd receives Rs. 108.17 crores IT demand notice for AY 2020-21
  • Jyoti Ltd receives order of Rs. 9.90 crores
  • Jyoti Ltd receives order worth Rs. 32.89 crores
  • Jyoti Ltd receives order of Rs. 14.94 crores
  • Jyoti Ltd receives LOI worth Rs. 16.16 crores
  • Jyoti Ltd receives order of Rs. 8.50 crores
  • Jyoti Ltd secures order from L&T
  • Jyoti Ltd secures order for Rs. 7.37 crore
  • Jyoti Ltd secures orders of Rs. 41 crores
  • Jyoti Ltd receives orders worth Rs. 19.50 crores
  • Jyoti Ltd secures order from Indian Oil Corporation Ltd
  • Jyoti Ltd secures order
  • Jyoti Ltd Q1 FY23 consolidated profit slides QoQ to Rs. 1.21 crore
  • Jyoti Ltd consolidated Q3 FY2021-22 profit at Rs. 3 lakhs
  • Jyoti Limited enters into OTS with Technology Development Board
  • Jyoti Ltd Q2FY22 consolidated loss at Rs. 3.05 crore

Latest Post

  • HCLTech joins MIT Media Lab in the US to collaborate on next-gen AI research
  • TVS Motor Company launches most advanced TVS Raider variant
  • Zydus receives final approval from USFDA for Deflazacort oral suspension, 22.75 mg/mL
  • Deepak Group Unveils State-of-the-Art Next-Generation R&D Centre to Pioneer Innovations in Chemistry
  • Smt. Bhuvaneswari Nara selected for IOD's Distinguished Fellowship - 2025


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024